Cancer surgeon Monica Bertagnolli emphasized her rural roots, experience treating patients, and desire to make treatments affordable
Monica Bertagnolli greets members of the Senate health committee before a hearing on her nomination as National Institutes of Health director.A Senate hearing today to consider the nomination of Monica Bertagnolli to lead the National Institutes of Health went well for the cancer surgeon. Committee Chair Bernie Sanders grilled Bertagnolli about NIH’s role in controlling drug prices, and Republican members pressed her on politically sensitive research.
Sanders opened the hearing by noting that people in the United States often pay much more than patients in other countries for drugs developed with NIH support. “We need an NIH director who is prepared to take on the greed of the pharmaceutical industry,” Sanders said. He wanted to know whether Bertagnolli would restore aclause to NIH contracts with companies to develop drugs that then–Director Harold Varmus removed in 1995 over concerns that it was dissuading companies from working with NIH.
Making NIH-developed treatments “available and affordable” is one of her three priorities as NIH director, Bertagnolli said. She also emphasized research—including fundamental biology, data analytics, social science—and more efficient and diverse clinical trials. Her third priority is to “restore faith and trust in our nation’s top scientists” and inspire young people to pursue biomedical careers, she said.
She told Senator Roger Marshall that she agrees NIH funding should be spread more evenly across the country, giving as an example a clinical trial where she enrolled patients in Laredo, Texas; a Native American reservation; and her hometown of Rock Springs, Wyoming. Partnering with community hospitals to find patients for trials, she said, is “one way we can engage more of the American people” in NIH research.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
RFK Jr. vows to reform NIH 'overnight' if electedGabrielle M. Etzel is the healthcare policy reporter for the Washington Examiner. Prior to joining the Washington Examiner, she served as a staff reporter at Campus Reform and as a freelance writer.
続きを読む »
Barabak: Laphonza Butler aces first political test, passing on uphill Senate runBy foregoing campaign that would have been hard to win, she’s well-positioned if she chooses to seek office later.
続きを読む »
12 Books About Breast Cancer That Will Change How You View This DiseaseWhether you're a patient, survivor, or a person who cares about someone with breast cancer, these books — including practical guides, heartfelt memoirs, and the latest research — will inform and inspire you.
続きを読む »
The FDA is proposing a ban on hair relaxers with formaldehyde due to cancer concernsThe federal agency says it is proposing a ban on the use of formaldehyde in hair straighteners and smoothers, which have been linked to increased cancer risks.
続きを読む »
Senator for Alabama heads to Middle East with Senate delegationU.S. Senator Katie Britt (R-Ala.) Friday announced that she departed for an official congressional trip the Middle East with a bipartisan delegation of Senate c
続きを読む »
Cancer Breakthrough: A Groundbreaking Solution to Metastasis & Chemotherapy ResistanceScience, Space and Technology News 2023
続きを読む »